Starpharma Holdings Ltd - Company Profile

Powered by

All the data and insights you need on Starpharma Holdings Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Starpharma Holdings Ltd Strategy Report

  • Understand Starpharma Holdings Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Starpharma Holdings Ltd: Overview

Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s development programs include its DEP drug delivery, which is built around dendrimers and VivaGel portfolio. Its flagship product candidate, VivaGel, is a gel-based formulation for the treatment and prevention of bacterial vaginosis (BV) and it is also used as a vaginal microbicide to prevent the sexually transmitted infections including HIV and genital herpes. It has license arrangements with several partners including Okamoto Industries and AstraZeneca among others. The company has research facilities in Melbourne, Australia. Starpharma is headquartered in Abbotsford, Victoria, Australia

Gain a 360-degree view of Starpharma Holdings Ltd and make more informed decisions for your business Gain a 360-degree view of Starpharma Holdings Ltd and make more informed decisions for your business Find out more
Headquarters Australia

Address Preston, Po Box 2022, Melbourne, Victoria, 3072


Telephone 61 3 85322700

No of Employees 50

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange SPL (ASX)

Revenue (2023) $2.9M -14.1% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 3.2% (2023 vs 2022)

Market Cap* $34.5M

Net Profit Margin (2023) XYZ -12.7% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Starpharma Holdings Ltd premium industry data and analytics

20+

Pipeline Drugs

Identify which of Starpharma Holdings Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Catalyst Calendar

Proactively evaluate Starpharma Holdings Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

19+

Clinical Trials

Determine Starpharma Holdings Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Starpharma Holdings Ltd’s relevant decision makers and contact details.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Marketed Drugs

Understand Starpharma Holdings Ltd’s commercialized product portfolio to stay one step ahead of the market.

Products and Services

Products Brands
Gel VivaGel
Condoms DEP
Nasal Spray Viraleze
Understand Starpharma Holdings Ltd portfolio and identify potential areas for collaboration Understand Starpharma Holdings Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Starpharma Holdings Ltd Rhinomed Ltd ResApp Health Ltd Immuron Ltd GLYDE Health Pty Ltd
Headquarters Australia Australia Australia Australia Australia
City Melbourne Richmond Brisbane Carlton Lindfield
State/Province Victoria Victoria Queensland Victoria New South Wales
No. of Employees 50 - 3 6 -
Entity Type Public Private Private Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Rob Thomas Chairman Executive Board 2014 -
Jacinth K Fairley Director; Chief Executive Officer Executive Board 2006 -
Justin Cahill Company Secretary; Chief Financial Officer Senior Management 2023 -
Jeremy Paull Vice President - Development and Regulatory Affairs Senior Management - -
Tony Eglezos Vice President - Business Development Senior Management 2013 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Starpharma Holdings Ltd key executives to enhance your sales strategy Gain insight into Starpharma Holdings Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?